Integral Health Asset Management LLC Has $60.91 Million Holdings in Tenet Healthcare Corporation $THC

Key Points

• Integral Health Asset Management raised its stake in Tenet Healthcare by 9.1% in Q3 to 300,000 shares (about $60.91M), making Tenet roughly 4.1% of the firm’s portfolio and 0.34% of Tenet outstanding.
• Tenet topped Q4 estimates with $4.70 EPS (vs. $4.08) and $5.53B revenue, provided FY2026 guidance of 16.190–18.470 EPS, and carries a consensus analyst rating of "Moderate Buy" with a ~$250.56 price target.
• Insiders have sold a total of 48,695 shares (~$11.37M) in the last 90 days while institutional investors own about 95.44% of the stock and insiders hold 0.81%.

Integral Health Asset Management LLC boosted its holdings in Tenet Healthcare Corporation (NYSE:THC - Free Report) by 9.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 300,000 shares of the company's stock after acquiring an additional 25,000 shares during the quarter. Tenet Healthcare accounts for about 4.1% of Integral Health Asset Management LLC's investment portfolio, making the stock its 3rd biggest position. Integral Health Asset Management LLC owned about 0.34% of Tenet Healthcare worth $60,912,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. William B. Walkup & Associates Inc. bought a new position in shares of Tenet Healthcare during the 3rd quarter worth approximately $32,000. Westside Investment Management Inc. raised its stake in Tenet Healthcare by 100.0% during the third quarter. Westside Investment Management Inc. now owns 192 shares of the company's stock worth $39,000 after acquiring an additional 96 shares in the last quarter. Canada Pension Plan Investment Board acquired a new stake in shares of Tenet Healthcare in the 2nd quarter valued at $35,000. Trust Co. of Vermont bought a new stake in shares of Tenet Healthcare in the 3rd quarter worth about $41,000. Finally, Geneos Wealth Management Inc. increased its position in shares of Tenet Healthcare by 50.9% during the 2nd quarter. Geneos Wealth Management Inc. now owns 264 shares of the company's stock worth $46,000 after purchasing an additional 89 shares in the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Tenet Healthcare Price Performance

THC opened at $227.79 on Friday. The company has a fifty day moving average price of $213.46 and a two-hundred day moving average price of $203.99. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. The firm has a market capitalization of $19.81 billion, a PE ratio of 14.71, a P/E/G ratio of 1.11 and a beta of 1.39. Tenet Healthcare Corporation has a 52 week low of $109.82 and a 52 week high of $247.21.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. The business had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The firm's revenue was up 8.9% on a year-over-year basis. During the same period last year, the company earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have weighed in on THC. Wells Fargo & Company reaffirmed an "overweight" rating and set a $265.00 price objective on shares of Tenet Healthcare in a research note on Monday, February 16th. Leerink Partners lifted their target price on shares of Tenet Healthcare from $255.00 to $264.00 and gave the company an "outperform" rating in a research note on Friday, February 20th. UBS Group increased their price target on Tenet Healthcare from $260.00 to $288.00 and gave the stock a "buy" rating in a research report on Thursday, February 12th. KeyCorp boosted their price objective on Tenet Healthcare from $225.00 to $250.00 and gave the stock an "overweight" rating in a research note on Thursday, February 12th. Finally, Royal Bank Of Canada raised their target price on Tenet Healthcare from $253.00 to $277.00 and gave the company an "outperform" rating in a research note on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, Tenet Healthcare has an average rating of "Moderate Buy" and a consensus price target of $250.56.

Insider Buying and Selling

In other news, Director Nadja West sold 2,178 shares of the company's stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the sale, the director directly owned 28,480 shares of the company's stock, valued at $5,623,945.60. This represents a 7.10% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Thomas W. Arnst sold 24,000 shares of Tenet Healthcare stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the transaction, the executive vice president directly owned 8,012 shares in the company, valued at $1,875,128.48. The trade was a 74.97% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 48,695 shares of company stock valued at $11,373,201 over the last 90 days. 0.81% of the stock is owned by corporate insiders.

Tenet Healthcare Profile

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.